Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Gagelmann N"'
Autor:
Gagelmann N; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Dima D; Cleveland Clinic Taussig Cancer Center, Cleveland, OH.; US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS., Merz M; Department of Hematology, Cellular Therapy, Hemostaseology and Infectiology, University Hospital of Leipzig, Leipzig, Germany., Hashmi H; US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS.; Medical University of South Carolina, Charleston, SC., Ahmed N; US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS.; The University of Kansas Medical Center, Kansas City, KS., Tovar N; Hospital Clínic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain., Oliver-Caldés A; Hospital Clínic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain., Stölzel F; Division for Stem Cell Transplantation and Cellular Immunotherapy, Department of Medicine II, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany., Rathje K; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Fischer L; Department of Hematology, Cellular Therapy, Hemostaseology and Infectiology, University Hospital of Leipzig, Leipzig, Germany., Born P; Department of Hematology, Cellular Therapy, Hemostaseology and Infectiology, University Hospital of Leipzig, Leipzig, Germany., Schäfer L; Department of Hematology and Medical Oncology, Medical Center University of Göttingen, Göttingen, Germany., Albici AM; Division for Stem Cell Transplantation and Cellular Immunotherapy, Department of Medicine II, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany., Schub N; Division for Stem Cell Transplantation and Cellular Immunotherapy, Department of Medicine II, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany., Kfir-Erenfeld S; Department of Bone Marrow Transplantation and Cancer Immunotherapy, Faculty of Medicine, Hadassah Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel., Assayag M; Department of Bone Marrow Transplantation and Cancer Immunotherapy, Faculty of Medicine, Hadassah Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel., Asherie N; Department of Bone Marrow Transplantation and Cancer Immunotherapy, Faculty of Medicine, Hadassah Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel., Wulf GG; Department of Hematology and Medical Oncology, Medical Center University of Göttingen, Göttingen, Germany., Kharboutli S; Department of Internal Medicine, Haematology and Oncology, University Hospital of Erlangen, Friedrich-Alexander University of Erlangen-Nuremberg (FAU), Erlangen, Germany., Müller F; Department of Internal Medicine, Haematology and Oncology, University Hospital of Erlangen, Friedrich-Alexander University of Erlangen-Nuremberg (FAU), Erlangen, Germany., Shune L; US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS.; The University of Kansas Medical Center, Kansas City, KS., Davis JA; US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS.; Medical University of South Carolina, Charleston, SC., Anwer F; Cleveland Clinic Taussig Cancer Center, Cleveland, OH.; US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS., Vucinic V; Department of Hematology, Cellular Therapy, Hemostaseology and Infectiology, University Hospital of Leipzig, Leipzig, Germany., Platzbecker U; Department of Hematology, Cellular Therapy, Hemostaseology and Infectiology, University Hospital of Leipzig, Leipzig, Germany., Ayuk F; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Kröger N; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Khouri J; Cleveland Clinic Taussig Cancer Center, Cleveland, OH., Gurnari C; Cleveland Clinic Taussig Cancer Center, Cleveland, OH.; Department of Biomedicine and Prevention, PhD in Immunology, Molecular Medicine and Applied Biotechnology, University of Rome Tor Vergata, Rome, Italy., McGuirk J; US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS.; The University of Kansas Medical Center, Kansas City, KS., Stepensky P; Department of Bone Marrow Transplantation and Cancer Immunotherapy, Faculty of Medicine, Hadassah Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel., Abdallah AO; US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS.; The University of Kansas Medical Center, Kansas City, KS., Fernández de Larrea C; Hospital Clínic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 May 10; Vol. 42 (14), pp. 1665-1675. Date of Electronic Publication: 2024 Feb 15.